T1	Action 22 29	predict
T2	Concept 30 35	drugs
R1	target Arg1:T1 Arg2:T2	
T3	Concept 44 49	M pro
T4	Concept 53 61	SARS-CoV
R2	has-part Arg1:T4 Arg2:T3	
T5	Concept 81 106	HIV-1 protease inhibitors
T6	Concept 115 124	lopinavir
T7	Concept 129 138	ritonavir
T8	Action 66 76	identified
R4	subject Arg1:T8 Arg2:T1	
R3	in-context Arg1:T2 Arg2:T3	
T9	Concept 153 163	candidates
R5	in-context Arg1:T9 Arg2:T2	
R6	is-a Arg1:T6 Arg2:T5	
R7	is-a Arg1:T7 Arg2:T5	
R8	is-a Arg1:T7 Arg2:T9	
R9	is-a Arg1:T6 Arg2:T9	
R10	target Arg1:T8 Arg2:T9	
T10	Action 179 183	bind
T11	Concept 203 207	site
T12	Concept 211 216	M pro
R11	has-part Arg1:T12 Arg2:T11	
R12	in-place Arg1:T10 Arg2:T11	
R13	subject Arg1:T10 Arg2:T7	
R14	subject Arg1:T10 Arg2:T6	
T13	Concept 275 294	protease inhibitors
T14	Concept 266 274	SARS-CoV
R15	in-context Arg1:T13 Arg2:T14	
T15	Concept 258 262	data
T16	Concept 245 257	experimental
R16	has-part Arg1:T15 Arg2:T16	
R17	in-context Arg1:T15 Arg2:T13	
T17	Concept 323 326	set
T18	Concept 314 322	training
R18	has-property Arg1:T17 Arg2:T18	
T19	Action 330 338	generate
T20	Concept 343 353	inhibitors
T21	Concept 357 366	2019-nCoV
T22	Concept 367 375	protease
R19	subject Arg1:T19 Arg2:T17	
R20	target Arg1:T19 Arg2:T20	
R21	in-context Arg1:T22 Arg2:T21	
R22	in-context Arg1:T20 Arg2:T22	
R23	is-a Arg1:T15 Arg2:T17	
T23	Concept 404 409	model
T24	Concept 391 403	mathematical
R24	has-property Arg1:T23 Arg2:T24	
T25	Concept 458 477	SARS-CoV-2-designed
T26	Concept 478 483	panel
R25	has-property Arg1:T26 Arg2:T25	
T27	Action 488 494	detect
T28	Action 430 439	estimated
R26	subject Arg1:T28 Arg2:T23	
R27	target Arg1:T28 Arg2:T27	
R28	subject Arg1:T27 Arg2:T26	
T29	Concept 495 499	1.15
T30	Concept 500 506	copies
T31	Concept 514 519	virus
R29	in-context Arg1:T29 Arg2:T30	
R30	in-context Arg1:T30 Arg2:T31	
T32	Concept 523 526	95%
T33	Concept 527 538	probability
R31	in-context Arg1:T32 Arg2:T33	
R32	target Arg1:T27 Arg2:T29	
R33	in-context Arg1:T27 Arg2:T32	
T34	Concept 584 598	binding energy
T35	Concept 607 625	interface sequence
T36	Concept 629 647	SARS-CoV-2 234 RBD
R34	has-part Arg1:T36 Arg2:T35	
R35	has-part Arg1:T36 Arg2:T34	
T37	Concept 662 670	SARS-CoV
T38	Concept 679 687	isolates
T39	Concept 671 678	related
R36	has-property Arg1:T38 Arg2:T39	
R37	in-context Arg1:T39 Arg2:T37	
T40	Concept 652 658	closer
R38	has-property Arg1:T35 Arg2:T40	
R39	has-property Arg1:T34 Arg2:T40	
R40	in-context Arg1:T40 Arg2:T38	
T41	Concept 733 741	SARS-CoV
T42	Concept 743 747	K929
T43	Concept 751 754	HR1
R41	in-place Arg1:T42 Arg2:T43	
T44	Concept 764 769	E1163
T45	Concept 773 776	HR2
R42	in-place Arg1:T44 Arg2:T45	
T46	Action 755 760;761 763	binds to
R43	subject Arg1:T46 Arg2:T42	
R44	target Arg1:T46 Arg2:T44	
T47	Concept 787 798	salt bridge
R45	in-context Arg1:T46 Arg2:T47	
T48	Concept 828 832	T925
T49	Action 856 867	interaction
R46	is-a Arg1:T46 Arg2:T49	
T50	Action 840 848	involved
A1	Negated T50
R47	subject Arg1:T50 Arg2:T48	
R48	target Arg1:T50 Arg2:T46	
